Skip to main content

Table 1 General information about the study population

From: Evaluation of the clinical value of shear wave elastography for early detection and diagnosis of diabetic peripheral neuropathy: a controlled preliminary prospective clinical study

 

CG

(n = 30)

DPN

(n = 38)

non-DPN

(n = 35)

Χ2/F

P

Sex(female/male)

12/18

16/22

15/20

0.057

0.972

Age(yr)

58.40 ± 14.32

58.61 ± 13.87

57.74 ± 14.64

0.036

0.965

BMI((kg/m2))

24.38 ± 3.45

24.78 ± 3.77

24.66 ± 3.03

0.117

0.890

Duration(years)

11.41 ± 8.240

6.31 ± 5.09

6.057

0.002

FBG(mmol/L)

9.25 ± 3.26

8.02 ± 3.48

0.019

0.125

HbA1C(%)

9.37 ± 2.22

8.59 ± 1.97

0.557

0.115

TC(mmol/L)

4.65 ± 1.01

4.30 ± 1.01

0.004

0.144

TG(mmol/L)

1.82 ± 1.21

1.69 ± 1.17

0.007

0.639

LDL(mmol/L)

2.90 ± 0.91

2.63 ± 0.84

0.033

0.195

  1. DPN:Diabetic peripheral neuropath; CG: Control group; BMI: Body mass index; FBG:Fasting blood glucose; HbA1C: Gycated hemoglobin glycosylated hemoglobin; TC: Total cholesterol; TG:Triglyceride; LDL: Low Density Lipoprotein